Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07014722

Contact Activation of Coagulation in Newly Inserted Central Catheters - a Randomized Controlled Trial

Led by Thomas Kander · Updated on 2026-02-18

88

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

T

Thomas Kander

Lead Sponsor

L

Lund University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating how four different types of central venous catheters (CVCs) affect the body's blood clotting system. CVCs are thin tubes placed in large veins to give medications, fluids, or take secure blood samples, but they can sometimes cause blood clots, leading to serious health issues. This randomized controlled trial aims to compare the impact on coagulation caused by these commonly used catheters to better understand clot formation after catheter insertion. Participants will be randomly assigned to receive one of four different two-lumen central venous catheters, each made of polyurethane but with different sizes or coatings, including antimicrobial and silver ion-embedded options. Blood samples will be taken twice from each catheter: once immediately after insertion without flushing, and once after flushing with saline and discarding the initial blood. These samples will then be tested with rotational thromboelastometry (ROTEM) and other coagulation tests to compare clotting times and related markers between catheter types and within the overall group. During the study, participants will undergo catheter placement followed by blood sample collection at two specific times. The blood will be processed and analyzed shortly after collection to measure clotting times, clot strength, and various coagulation factors. The main outcome is the change in clotting time between the two samples. This information will help researchers identify how different catheters interact with blood clotting and could lead to safer catheter use and better prevention of clot-related complications. Participants will be monitored throughout the procedure and sample collection process, which is expected to last a short time after catheter insertion.

CONDITIONS

Brief Title

Contact Activation of Coagulation in Newly Inserted Central Venous Catheters

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinical need for insertion of a two-lumen central venous catheter with length 150-160 mm
  • Age 18 years or older
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Current use of anticoagulants or platelet inhibitors, except prophylactic low molecular weight heparin or acetylsalicylic acid
  • Abnormal prothrombin time (pK/INR outside 0.9-1.2), platelet count below 50 x 10⁹/L, or hemoglobin below 80 g/L if known
  • Known coagulopathic conditions such as activated protein C resistance, hemophilia A or B, vitamin K deficiency, disseminated intravascular coagulation, antiphospholipid syndrome, von Willebrand disease, or other bleeding disorders

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Single day procedure

Participants receive insertion of one of four types of central venous catheters as assigned by randomization. Blood samples are collected immediately after catheter insertion and after flushing the catheter.

1 catheter insertion visit with 2 blood sample collections

Monitoring

Duration - Within 1 hour after catheter insertion

Participants have coagulation parameters measured from collected blood samples to evaluate clotting times and other blood coagulation markers.

Blood samples processed and analyzed within 3 hours of collection; no additional participant visits required

Trial Site Locations

Total: 1 location

1

Skåne University Hospital Lund

Lund, Skåne County, Sweden, 22242

Actively Recruiting

Loading map...

Research Team

T

Thomas Kander, Professor

A

Aida Zorlak, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Similar Trials

Relationship Between Cellular Immunity Components and Neuroe...

Acute Coronary Syndrome

Actively Recruiting

1 location

A Randomised Feasibility Study of Real-time Intracavity ECG ...

Central Venous Catheter

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here